Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
114
datasets available to search
ShareScore release 0.9.0
Dataset results
114 results for “PD-L1 expression;”
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma [RNA-Seq]
GEO Series GSE107620. Homo sapiens. 12 samples. Type: Expression profiling by high throughput sequencing.
Therapeutic decoupling of MHC-I and PD-L1 expression increases the efficacy of immune checkpoint blockade
GEO Series GSE149826. Mus musculus. 56 samples. Type: Genome binding/occupancy profiling by high throughput sequencing; Other; Expression profiling by high throughput sequencing.
PRMT5 inhibition increases PD-L1 expression and immunoresistance in lung cancer
GEO Series GSE178521. Homo sapiens. 6 samples. Type: Expression profiling by high throughput sequencing.
DENR controls JAK2 translation to induce PD-L1 expression for tumor immune evasion
GEO Series GSE183980. Mus musculus. 8 samples. Type: Expression profiling by high throughput sequencing.
Genome-wide analysis reveals the repression of MORC3 on PD-L1 expression in head and neck cancer
GEO Series GSE254613. Homo sapiens. 6 samples. Type: Expression profiling by high throughput sequencing.
TET2 inhibits PD-L1 gene expression in breast cancer cells through histone deacetylation
GEO Series GSE164032. Homo sapiens. 6 samples. Type: Expression profiling by high throughput sequencing.
Expression data in PD-L1 positive and PD-L1 negative human melanoma samples
GEO Series GSE65041. Homo sapiens. 11 samples. Type: Expression profiling by array.
SMARCAL1 is a dual regulator of innate immune signaling and PD-L1 expression that promotes tumor immune evasion [ATAC-seq]
GEO Series GSE245447. Homo sapiens; Mus musculus. 14 samples. Type: Genome binding/occupancy profiling by high throughput sequencing.
68Ga-NK224 PET Imaging of PD-L1 Expression in Cancers
ClinicalTrials.gov study NCT06754345. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Immunohistochemical Expression of PD-L1 in Pancreatic Ductal Adenocarcinoma
ClinicalTrials.gov study NCT05228808. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Single-arm, Multicenter Exploratory Clinical Trial of Anlotinib Combined With TQB2450 and the SOX Regimen as First-line Treatment for Advanced Gastric Cancer With Low PD-L1 Expression
ClinicalTrials.gov study NCT06939452. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
PD-L1 Expression in Advanced Osteosarcoma
ClinicalTrials.gov study NCT03582527. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Atezolizumab in High PD-L1 Expression, Chemotherapy-Naïve Patients With Stage IV Non-Squamous or Squamous Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT05047250. IPD Sharing: YES. Countries: 1. Publications: 0.
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥
ClinicalTrials.gov study NCT06561386. IPD Sharing: YES. Countries: 30. Publications: 0.
Alectinib in Combination with Nivolumab in the Treatment of Recurrent or Refractory HCC Patients Guided with Serum RNase1 and Tumor Expression of PD-L1
ClinicalTrials.gov study NCT06354387. IPD Sharing: NO. Countries: 1. Publications: 0.
An Epidemiologic Study on PD-L1 Expression Combined With Clinical Observation in the Chinese MIUBC Patients.
ClinicalTrials.gov study NCT03433924. IPD Sharing: NO. Countries: 1. Publications: 0.
Evaluation of PD-L1 (Programmed Death-Ligand 1) Tumor Expression in Patients With Large-cell Neuroendocrine Carcinoma (NEC)
ClinicalTrials.gov study NCT03305133. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
PD-L1 Expression on CTCs in HNSCC Patients Underwent Curative CCRT
ClinicalTrials.gov study NCT05008796. IPD Sharing: NO. Countries: 1. Publications: 0.
Prevalence of PD-L1 Expression in Patients With Advanced Urothelial Carcinoma
ClinicalTrials.gov study NCT03788746. IPD Sharing: YES. Countries: 1. Publications: 0.
Study of Novel Treatment Combination Therapies in Participants With Head and Neck Squamous Cell Carcinoma Regardless of PD-L1 Expression Status; Substudy-01
ClinicalTrials.gov study NCT06727565. IPD Sharing: NO. Countries: 9. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.